EFFICACY AND SAFETY OF CHEMO-IMMUNOTHERAPY IN RECURRENT/METASTATIC HNSCC: A RETROSPECTIVE ANALYSIS

被引：0
|
作者：
Salvestrini, Viola [1 ]
Frosini, Giulio [1 ]
Desideri, Isacco [1 ]
Becherini, Carlotta [1 ]
Angelini, Lucia [1 ]
Bonomo, Pierluigi [1 ]
Livi, Lorenzo [1 ]
机构：
[1] Univ Florence, Radiat Oncol Unit, Azienda Osped Univ Careggi, Florence, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 192卷
关键词：
Immunotherapy; recurrent and metastatic HNSCC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
144
引用
收藏
页码：S167 / S168
页数：3
相关论文
共 50 条
  • [21] Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC
    Tanaka, Kentaro
    Sugisaka, Jun
    Shiraishi, Yoshimasa
    Watanabe, Yasutaka
    Daga, Haruko
    Azuma, Koichi
    Nishino, Kazumi
    Mori, Masahide
    Ota, Takayo
    Saito, Haruhiro
    Hata, Akito
    Sakaguchi, Tadashi
    Kozuki, Toshiyuki
    Akamatsu, Hiroaki
    Matsumoto, Hirotaka
    Tachihara, Motoko
    Wakuda, Kazushige
    Sato, Yuki
    Ozaki, Tomohiro
    Tsuchiya-Kawano, Yuko
    Yamamoto, Nobuyuki
    Nakagawa, Kazuhiko
    Okamoto, Isamu
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [22] The immune phenotype in serial biopsies from metastatic TNBC undergoing chemo-immunotherapy
    Deng, Jiehui
    Shah, Suhagi
    Thennavan, Aatish
    Krogsgaard, Michelle
    Perou, Charles M.
    Wong, Kwok-Kin
    Adams, Sylvia
    CANCER RESEARCH, 2019, 79 (13)
  • [23] Chemo-immunotherapy and surgery in the osteosarcoma metastatic of pediatric age: results of a monoinstitutional study
    Cefalo, G.
    Luksch, R.
    Casanova, M.
    Ferrari, A.
    Terenziani, M.
    Spreafico, F.
    Polastri, D.
    Catania, S.
    Podda, M.
    Meazza, C.
    Schiavello, E.
    Gandola, L.
    Daolio, P.
    Mapelli, S.
    Parafioriti, A.
    Marchiano, A.
    Massimino, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S14 - S14
  • [24] North-South Divide: Chemo-Immunotherapy Combination in Head and Neck Squamous Cell Cancer (HNSCC)
    Boon, I. S.
    Boon, C. S.
    Oguejiofor, K.
    Ramkumar, S.
    CLINICAL ONCOLOGY, 2024, 36 (06) : e169 - e169
  • [25] Tumor Clearance Analysis on a Cancer Chemo-Immunotherapy Mathematical Model
    Paul A. Valle
    Luis N. Coria
    Yolocuauhtli Salazar
    Bulletin of Mathematical Biology, 2019, 81 : 4144 - 4173
  • [26] Comparison of the efficacy and safety of Rituximab (Mabthera (TM)) and its biosimilar (Reditux (TM)) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis
    Roy, Partha Sarathi
    John, Shiji
    Karankal, Sadashiv
    Kannan, Sadhana
    Pawaskar, Preeti
    Gawande, Jayanta
    Bagal, Bhausaheb
    Khattry, Navin
    Sengar, Manju
    Menon, Hari
    Gujral, Sumeet
    Nair, Reena
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2013, 34 (04) : 292 - 298
  • [27] Tumor Clearance Analysis on a Cancer Chemo-Immunotherapy Mathematical Model
    Valle, Paul A.
    Coria, Luis N.
    Salazar, Yolocuauhtli
    BULLETIN OF MATHEMATICAL BIOLOGY, 2019, 81 (10) : 4144 - 4173
  • [28] Retrospective analysis of the safety of Herceptin® immunotherapy in metastatic breast cancer
    Cook-Bruns, N
    ONCOLOGY, 2001, 61 : 58 - 66
  • [29] Multicenter phase II study of chemo-immunotherapy in the treatment of metastatic breast cancer (MBC)
    Recchia, F.
    Saggio, G.
    Di Blasio, A.
    Amiconi, G.
    Candeloro, G.
    Necozione, S.
    Rea, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC).
    Scheff, Nicole N.
    Nilsen, Marci Lee
    Li, Jinhong
    Harris, Alexandria L.
    Swartz, Andrew
    Hsieh, Ronan Wenhan
    Anderson, Jennifer Lynn
    Ferris, Robert L.
    Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345